Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling

Molecular Pharmacology

Volumn 58, Issue 4, 2000, Pages 659-668

  Houslay, Miles D ^a,c   Kolch, Walter ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE KINASE RECEPTOR;

CELL TYPE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SECOND MESSENGER; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0033807228     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.4.659     Document Type: Short Survey

References (72)

1. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase (PDE4) family form a discrete module via electrostatic interactions
2. A novel regulatory mechanism of MAP kinase activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase
3. Characterisation of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phsohodiesterase PDE4D gene
4. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms
5. Crosstalk between protein kinase A and growth factor receptor pathways in arterial smooth muscle
6. Functional compartmentation of cyclic AMP and protein kinase in heart
7. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor
8. BCL-2 family: Regulators of cell death
9. AKAPs: From structure to function
10. The molecular biology of cyclic nucleotide phosphodiesterases
11. Inhibition by cAMP of ras-dependent activation of raf
12. Switching off the coupling of the beta2-adrenergic receptor to different G-proteins by protein kinase A
13. Cellular survival: A play in three Akts
14. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro
15. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
16. Extracellular ATP-mediated phospholipase A(2) activation in rat thyroid FRTL-5 cells: Regulation by a G(i)/G(o) protein, Ca(2+) and mitogen-activated protein kinase
17. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 mealanoma cells
18. New insights into the control of MAP kinase pathways
19. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells
20. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase
21. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase C pathways
22. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1
23. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells
24. Mechanism of inhibition of Raf-1 by protein kinase A
25. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
26. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase. HSPDE4D3 by phosphorylating it at Ser579
27. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model
28. cAMP abrogates the p21(ras)-mitogen-activated protein kinase pathway in fibroblasts
29. Tailoring cAMP signalling responses through isoform multiplicity
30. The multi-enzyme PDE4 cyclic AMP specific phosphodiesterase family: Intracellular targeting, regulation and selective inhibition by compounds exerting anti-inflammatory and anti-depressant actions
31. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase
32. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions
33. A family of cAMP-binding proteins that directly activate Rap1
34. Signal transduction through MAP kinase cascades
35. cPLA2 is phosphorylated and activated by MAP kinase
36. ERK2 MAP kinase binding, phosphorylation and regulation of PDE4D cAMP specific phosphodiesterases: The involvement of C-terminal docking sites and N-terminal UCR regions
37. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor
38. Association with the src family tyrosyl kinase lyn triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B: Consequences for rolipram inhibition
39. Negative regulation of Raf-1 by phosphorylation of serine 621
40. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein
41. Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP
42. Bradykinin stimulates cAMP synthesis via mitogen-activated protein kinase-dependent regulation of cytosolic phospholipase A2 and prostaglandin E2 release in airway smooth muscle
43. Asthma therapy for the 21st century
44. Acetylcholine muscarinic m1 receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity
45. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase
46. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
47. Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae
48. Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway
49. Increasing cAMP attenuates activation of mitogen-activated protein kinase
50. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
51. Mammalian adenylyl cyclases
52. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo
53. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
54. Identification of Raf-1 Ser621 kinase activity from NIH 3T3 cells as AMP-activated protein kinase
55. The juxtamembrane, cytosolic region of the epidermal growth factor receptor is involved in association with alpha-subunit of Gs
56. Complexity and diversity of mammalian adenylyl cyclases
57. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf
58. p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway
59. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity
60. Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: From concept to clinic
61. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity
62. B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP
63. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway
64. Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells
65. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate
66. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
67. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
68. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor
69. The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform
70. Suppression of Raf-1 kinase activity and MAP kinase signaling by RKIP
71. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
72. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm